WiStride, an Integrated B2B Platform for active pharmaceutical ingredients (APIs), intermediates, and raw materials, launched its new digital platform. The event was attended by Satish Khanna, chairman, of Fullife Healthcare, ex-group president, lupin among others. 

The newly launched platform will connect buyers and suppliers through its new digital platform, leading to cost-saving advantages and improved operational efficiency. The company will also offer supply chain financing options to help fund working capital requirements for clients once they have identified the right partners using their platform, the company said in a statement. 

At the launch programme, Dr Madhu Talla, co-founder, WiStride, said, “WiStride is set to transform the way pharma buyers and sellers navigate this landscape, creating a seamless journey that empowers both sides. It’s not just about transactions; it’s also about AI-enabled intelligence-powered transformation.”

WiStride’s services include Wistride Edge and WiStride Commerce. WiStride Edge leverages the power of data intelligence to provide vital market intelligence that directly addresses the business challenges faced by clients. These insights are rooted in comprehensive global research, real-time market dynamics, and extensive domain expertise and state-of-the-art data science. This helps clients make agile and well-informed decisions. WiStride Commerce, dedicated towards transforming the pharmaceutical Business-to-Business (B2B) commerce landscape, aims to create a trusted and transparent ecosystem.